Concepedia

Sarah Atkinson

SA

8

Publications

560

Citations

8

H-Index

1994

Active since

Affiliations

VA Finger Lakes Healthcare System(Current)

AstraZeneca (United States)

Northwest Clinical Research Center

Wilmington University

Bellevue Hospital Center

Sarah Atkinson is an author at VA Finger Lakes Healthcare System specializing in psychopharmacology, psychopathology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1994–2023

8

Publications

8

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study

Nizar El-Khalili, Mark Joyce, Sarah Atkinson et al. · The International Journal of Neuropsychopharmacology · 2010 · 178 citations · Full text

Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study

Gerard Sanacora, Michael R. Johnson, Arif Khan et al. · Neuropsychopharmacology · 2016 · 114 citations · Full text

A Double-Blind Efficacy and Safety Study of Duloxetine Flexible Dosing in Children and Adolescents with Major Depressive Disorder

Sarah Atkinson, Apurva Prakash, Qi Zhang et al. · Journal of Child and Adolescent Psychopharmacology · 2014 · 77 citations

A Randomized, Double-Blind Study of Once-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients With Generalized Anxiety Disorder

Arifulla Khan, Mark Joyce, Sarah Atkinson et al. · Journal of Clinical Psychopharmacology · 2011 · 65 citations

, , +15

Grieving and loss in parents with a schizophrenic child

Sarah Atkinson · American Journal of Psychiatry · 1994 · 54 citations

Rows per page

1–5 of 8